Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
CALL
B&G Foods
BGS
$282M
| $4.7M | ﹤0.01% |
95,500
-22,200
| -19% | -$1.07M |
|
2302
CALL
Community Health Systems
CYH
$410M
| $4.69M | ﹤0.01% |
406,800
-147,500
| -27% | -$1.7M |
|
|
WPZ
2303
DELISTED
Williams Partners L.P.
WPZ
| $4.69M | ﹤0.01% |
126,200
-26,610
| -17% | -$979K |
|
2304
CALL
El Pollo Loco
LOCO
$468M
| $4.69M | ﹤0.01% |
372,700
+239,300
| +179% | +$3.21M |
|
|
AKS
2305
PUT
DELISTED
AK Steel Holding Corp
AKS
| $4.69M | ﹤0.01% |
971,200
-408,300
| -30% | -$2.07M |
|
2306
PUT
Prothena Corp
PRTA
$465M
| $4.69M | ﹤0.01% |
78,200
-68,700
| -47% | -$3.69M |
|
2307
CALL
Crane NXT
CXT
$2.87B
| $4.69M | ﹤0.01% |
214,198
-1,727
| -0.8% | -$37.2K |
|
2308
PUT
Cedar Fair
FUN
$1.65B
| $4.69M | ﹤0.01% |
81,800
-37,000
| -31% | -$2.2M |
|
2309
TotalEnergies
TTE
$192B
| $4.68M | ﹤0.01% |
98,190
+451
| +0.5% | +$21.6K |
|
2310
Zimmer Biomet
ZBH
$19.1B
| $4.68M | ﹤0.01% |
37,080
-2,238
| -6% | -$277K |
|
|
COHR
2311
CALL
DELISTED
Coherent Inc
COHR
| $4.68M | ﹤0.01% |
42,300
+24,700
| +140% | +$2.56M |
|
2312
CALL
Public Service Enterprise Group
PEG
$36.6B
| $4.67M | ﹤0.01% |
111,500
-47,300
| -30% | -$2.08M |
|
2313
Assured Guaranty
AGO
$3.31B
| $4.66M | ﹤0.01% |
167,932
| – | – |
|
|
ONIT
2314
CALL
Onity Group
ONIT
$286M
| $4.66M | ﹤0.01% |
84,653
+4,380
| +5% | +$179K |
|
2315
CALL
WEC Energy
WEC
$34.8B
| $4.66M | ﹤0.01% |
77,800
-27,500
| -26% | -$1.72M |
|
2316
Canadian Solar
CSIQ
$927M
| $4.66M | ﹤0.01% |
338,851
+204,099
| +151% | +$2.81M |
|
|
KANG
2317
PUT
DELISTED
iKang Healthcare Group, Inc.
KANG
| $4.66M | ﹤0.01% |
257,400
+168,200
| +189% | +$3.09M |
|
2318
CALL
Molina Healthcare
MOH
$10.4B
| $4.65M | ﹤0.01% |
79,800
+7,400
| +10% | +$408K |
|
|
GNC
2319
CALL
DELISTED
GNC Holdings, Inc.
GNC
| $4.65M | ﹤0.01% |
227,600
+48,000
| +27% | +$1.05M |
|
2320
PUT
Universal Health Services
UHS
$10.3B
| $4.64M | ﹤0.01% |
37,700
-25,500
| -40% | -$3.23M |
|
|
MMP
2321
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $4.64M | ﹤0.01% |
65,660
+19,760
| +43% | +$1.41M |
|
2322
New Oriental
EDU
$9.28B
| $4.63M | ﹤0.01% |
99,890
-16,141
| -14% | -$700K |
|
2323
CALL
Huntington Bancshares
HBAN
$34B
| $4.63M | ﹤0.01% |
469,500
-45,200
| -9% | -$430K |
|
2324
CALL
Casey's General Stores
CASY
$28.9B
| $4.63M | ﹤0.01% |
38,500
+9,700
| +34% | +$1.25M |
|
|
STI
2325
DELISTED
SunTrust Banks, Inc.
STI
| $4.63M | ﹤0.01% |
105,600
| – | – |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.